Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05583708 |
|---|---|
| Brief Title: | Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer (iPRRT) |
| First Submitted : | October 12, 2022 |
| First Submitted that Met QC Criteria : | October 12, 2022 |
| First Posted : | October 18, 2022 |
| Last Update Submitted that Met QC Criteria : | April 15, 2024 |
| Last Update Posted : | April 17, 2024 |